Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Another study suggests that weight-loss meds like Wegovy (NVO) and Mounjaro (LLY) can help people cut back on drinking ...

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...